Effect of agmatine on long-term potentiation in morphine-treated rats

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 2, 2010, Pages 125-129

  Lu, Wei ^a   Dong, Hua Jin ^a   Bi, Guo Hua ^a   Zhao, Yong Qi ^a   Yang, Zheng ^a   Su, Rui Bin ^a   Li, Jin ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Agmatine; Idazoxan; Imidazoline receptor; LTP; Morphine

Indexed keywords

AGMATINE; IDAZOXAN; IMIDAZOLINE RECEPTOR; MORPHINE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; GRANULE CELL; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NONHUMAN; PERFORANT NERVE TRACT; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG INTERACTION; PHYSIOLOGY; WISTAR RAT;

AGMATINE; ANIMALS; DENTATE GYRUS; DRUG INTERACTIONS; HIPPOCAMPUS; IDAZOXAN; IMIDAZOLINE RECEPTORS; LONG-TERM POTENTIATION; MALE; MORPHINE; RATS; RATS, WISTAR;

RATTUS;

EID: 77953702263     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.04.019     Document Type: Article

References (43)

1. Aricioglu F., Ercil E., Dulger G. Agmatine inhibits naloxoneinduced contractions in morphine-dependent guinea pig ileum. Ann NY Acad Sci 2003, 1009:147-151.
2. Aricioglu F., Korcegez E., Bozkurt A. Effect of agmatine on acute and mononeuropathic pain. Ann NY Acad Sci 2003, 1009:106-115.
3. Aricioglu F., Means A., Regunathan S. Effect of agmatine on the development of morphine dependence in rats: potential role of cAMP system. Eur J Pharmacol 2004, 504:191-197.
4. Aricioglu-Kartal F., Uzbay I.T. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome. Life Sci 1997, 61:1775-1781.
5. Arteni N.S., Lavinsky D., Rodrigues A.L., et al. Agmatine facilitates memory of an inhibitory avoidance task in adult rats. Neurobiol Learn Mem 2002, 78:465-469.
6. Bohn L.M., Gainetdinov R.R., Lin F.-T., et al. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 2000, 408:720-723.
7. Doyle C., Holscher, Rowan M.J., Anwyl R. The selective neuronal NO synthase inhibitor 7-nitro-indazole blocks both long-term potentiation and depotentiation of field EPSPs in rat hippocampal CA1 in vivo. J Neurosci 1996, 16:418-424.
8. Eisch A.J., Barrot M., Schad C.A., et al. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci 2000, 97:7579-7584.
9. Fairbanks C.A., Wilcox G.L. Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther 1997, 282:1408-1417.
10. Frank D.A., Greenberg M.E. CREB: a mediator of long-term memory from mollusks to mammals. Cell 1994, 79:5-8.
11. Galea E., Regunathan S., Eliopoulos V., et al. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996, 316:247-249.
12. Giorgetti M., Hotsenpiller G., Ward P., et al. Amphetamine-induced plasticity of AMPA receptors in the ventral tegmental area: effects on extracellular levels of dopamine and glutamate in freely moving rats. J Neurosci 2001, 21:6362-6369.
13. Harrison J.M., Allen K.G., Pellegrino M.J., et al. Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission. J Neurophysiol 2002, 87:2464-2470.
14. Huang Y.Y., Li X.C., Kandel E.R. cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase. Cell 1994, 79:69-79.
15. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001, 2:695-703.
16. Ito Yoshihisa, Tabata Keiichi, Makimura Mizue, Fukuda Hideomi Acute and chronic intracerebroventricular morphine infusions affect long-term potentiation differently in the lateral perforant path. Pharmacol Biochem Behav 2001, 70:353-358.
17. Kalra S.P., Pearson E., Sahu A., et al. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci Lett 1995, 194:165-168.
18. Kolesnikov Y., Jain S., Pasternak G.W. Modulation of opioid analgesia by agmatine. Eur J Pharmacol 1996, 296:17-22.
19. Li G., Regunathan S., Barrow C.J., et al. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994, 263:966-969.
20. Li J., Li X., Pei G., Qin B.Y. Agmatine inhibited tolerance to and dependence on morphine in guinea pig ileum in vitro. Zhongguo Yao Li Xue Bao 1998, 19:564-568.
21. Li J., Li X., Pei G., Qin B.Y. Effects of agmatine on tolerance to and substance dependence on morphine in mice. Zhongguo Yao Li Xue Bao 1999, 20:232-238.
22. Mckay B.E., Persinger M.A. Combined effects of complex magnetic fields and agmatine for contextual fear learning deficits in rats. Life Sci 2003, 72:2489-2498.
23. Piletz J.E., Chikkala D.N., Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther 1995, 272:581-587.
24. Pineda J., Ruiz-Ortega J.A., Martín-Ruiz R., et al. Agmatine does not have activity at alpha2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: an electrophysiological study in rat. Neurosci Lett 1996, 219:103-106.
25. Pinthoug D., Wright I.K., Hammer C., et al. Agmatine recognizes α2-adrenoceptor binding site but neither activates nor inhibits α2-adrenoceptors[J]. Naunyn-Schmiedeberg's Arch Pharmacol 1995, 351(1):10-16.
26. Pu L., Bao G.B., Xu N.J., et al. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J Neurosci 2002, 22:1914-1921.
27. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol Sci 2000, 21:187-193.
28. Robbins T.W., Everitt B.J. Drug addiction: bad habits add up. Nature 1999, 398:567-570.
29. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997, 17:8491-8497.
30. Robinson T.E., Gorny G., Mitton E., et al. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001, 39:257-266.
31. Ruiz-Ortega J.A., Ugedo L. The stimulatory effect of clonidine on locus coeruleus neurons of rats with inactivated alpha2-adrenoceptors: involvement of imidazoline receptors located in the nucleus paragigantocellularis. Naunyn-Schmiedeberg's Arch Pharmacol 1997, 355:288-294.
32. Salmanzadeh F., Fathollahi Y., Semnanian S., et al. Dependence on morphine impairs the induction of long-term potentiation in the CA1 region of rat hippocampal slices. Brain Res 2003, 965:108-113.
33. Simmons M.L., Chavkin C. Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol 1996, 39:145-196.
34. Takamatsu I., Iwase A., Ozaki M., et al. Dexmedetomidine reduces long-term potentiation in mouse hippocampus. Anesthesiology 2008, 108:94-102.
35. Wang L.G., Gao L., Wang W., et al. sympathoexcitation of moxonidine in the caudal ventrolateral medulla is dependent on I1-imidazoline receptors in anesthetized rats. Neurosci Lett 2007, 426:91-96.
36. Wei Xiao-Li, Su Rui-Bin, Lu Xin-Qiang, et al. Inhibition by agmatine on morphine-induced conditioned place preference in rats. Eur J Pharmacol 2005, 515:99-106.
37. Weisskopf M.G., Zalutsky R.A., Nicoll R.A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fiber synapses and modulates long-term potentiation. Nature 1993, 362:423-427.
38. Weisskopf M.G., Castillo P.E., Zalutsky R.A., et al. Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science 1994, 265:1878-1882.
39. Wolf M.E. Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol Interv 2002, 2:146-157.
40. 1A receptor mRNA of central nerves system in morphine withdrawal rats. Int J Anesth Resus 2006, 27(4):218-220.
41. Xu L., Anwyl R., Rowan M.J. Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature 1997, 387:497-500.
42. Yang X.C., Reis D.J. Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 1999, 288:544-549.
43. Yesilyurt O., Uzbay I.T. Agmatine potentiates the analgesic effect of morphine by an alpha(2)-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology 2001, 25:98-103.